Innovative oil-laden capsules designed for controlled release in the digestive system to reduce appetite by triggering the ileal brake. Compatible with standard food processing, these capsules present a ready-to-market solution for managing food intake.
IamFluidics presents a breakthrough in appetite control with the development of controlled-release oil capsules. These capsules are engineered to release free fatty acids in the ileum, triggering the ileal brake mechanism, which effectively reduces appetite. This innovation is grounded in successful pilot-scale production and compatibility with standard food processing techniques, marking a significant step towards market-ready solutions for appetite management.
This technology is at TRL 5, indicating that it has been validated in relevant environments and is moving towards commercial deployment. Further validation phases are planned to solidify its readiness for market entry.
IamFluidics is a high-tech company focused on designing and manufacturing microparticle and microcapsule solutions for applications that include controlled delivery, injectables, and protection of sensitive bioactives and live cells, using its patented microencapsulation platform and in-house development and production capabilities.